Prudêncio Lab

2021/2024 -  Whole-organism vaccines against P. falciparum and P. vivax malaria with enhanced efficacy and scope. 'la Caixa' Foundation. Abstract here.

Coordinator: Miguel Prudêncio, 987.000€.

2021/2022 - Generation, characterization and in vivo evaluation of a novel live malaria vaccine. GSK Tres Cantos Open Lab Foundation. Abstract here.

Coordinator: Miguel Prudêncio, 160.000€.

2018/2021 - Enabling strategies for enhanced whole-sporozoite malaria vaccines. FCT

Coordinator: Miguel Prudêncio, 234.000€. Abstract here.  Click on the image on the right to see the graphical abstract.

2017/2019 - Production and maintenance of Plasmodium-infected mosquitoes. Merck

Coordinator: Miguel Prudêncio, 112.000 €

2017/2018 - A P. berghei-based vaccine against Malaria. PATH Malaria Vaccine Initiative

2016/2018 - 3D hepatic cell models of Plasmodium infection. Instituto de Biologia Experimental e Tecnológica (iBET) / Merck

Coordinator: Miguel Prudêncio, 75.000 €. Abstract here. Click on the image on the right to see the graphical abstract.

2016/2019 - Improving whole organism vaccines against malaria by genetic modification. FCT

Coordinator: António Mendes. PTDC/BBBBMD/2695/2014, 197.648,00 €. Abstract here. Click on the image on the right to see the graphical abstract.

2016/2018 - TwinnToInfect. European Commission, H2020 Twinning, EU
Coordinator: Maria Mota. Project reference: 692022, 1.000.000,00 €. Science- and innovation-driven clustering of Instituto de Medicina Molecular (iMM Lisboa), the Institut Pasteur and the Francis Crick Institute. Click here or on the image on tyhe right for more details.

2012/2015 - Towards malaria eradication. A novel approach for multi-targeting the parasite´s life cycle. FCT

Coordinator: Francisca Lopes (iMed). PTDC/SAU-FAR/118459/2010, 36.000 €

2012/2015 - Utilization of host cell resources by the malaria parasite in the liver. FCT.

Coordinator: Miguel Prudêncio. PTDC/SAU-MIC/117060/2010, 154.755,00 €. Abstract here. Click on the image on the right to see the graphical abstract.

2010/2013 - The influence of bile acids on malaria liver infection. FCT.

Coordinator: Miguel Prudêncio. PTDC/SAU-MII/099118/2008, 171.482,00 €. Abstract here. Click on the image on the right to see the graphical abstract.

2010/2012 - A new whole-organism vaccine against Malaria. Grand Challenges Explorations - GCE OPP1025634, Phase I, Bill & Melinda Gates Foundation.

Coordinator: Miguel Prudêncio, 100.000,00 USD. Press release here. Click on the image on the right to see the graphical abstract.

2013/2017 - A new whole-organism vaccine against Malaria. Grand Challenges Explorations - GCE OPP1025634, Phase II, Bill & Melinda Gates Foundation.

Coordinator: Miguel Prudêncio, 1.218.000,00 USD (Oct 2013), 138.865,00 USD (Sep 2014), 334.388,00 USD (Feb 2015) (Total 1.692.078,00 USD). Press release here. Click on the image on the right to see the graphical abstract.

2015/2017 - A P. berghei-based vaccine against Malaria. PATH Malaria Vaccine Initiative.

Coordinator: Miguel Prudêncio, 210.695,00 USD. Click on the image on the right to see the graphical abstract.